Huang Ziling, Liang Xin, Luo Yuheng, Fang Zhou, Xu Ming, Xu Yinqin, Cheng Shan, Li Lihong
Department of Acupuncture and Moxibustion, The Affiliated Hospital of Guizhou Medical University, Guizhou, People's Republic of China.
Department of Orthopedics, The Affiliated Hospital of Guizhou Medical University, Guizhou, People's Republic of China.
J Pain Res. 2025 Jan 28;18:497-506. doi: 10.2147/JPR.S492541. eCollection 2025.
Plantar fasciitis is a common cause of heel pain, often associated with a higher rate of low back pain. This increased disability rate in low back pain may be correlated with reduced foot and ankle function. While both acupuncture and trigger point dry needling have been reported as potentially effective treatments for plantar fasciitis, the quality of evidence is currently low. Acupuncture at trigger points might be a promising treatment for plantar fasciitis, though there is a lack of evidence supporting its effectiveness. This trial aims to compare the effectiveness of acupuncture at trigger points versus Traditional Chinese Medicine (TCM) acupoints in the treatment of participants with plantar fasciitis and low back pain.
The trial will be a single-centre, parallel two-group, randomised controlled trial with 62 participants allocated in a 1:1 ratio to either the trigger point group or the TCM acupoint group. Patients with plantar fasciitis and low back pain will be enrolled in this trial. Eligible participants will receive acupuncture for 30 minutes per session over 8 total sessions, with a 12-week follow-up period. The primary outcome measure will be the change from baseline in the worst first-step pain intensity in the morning after treatment. Secondary outcomes include changes from baseline in foot and low back pain, foot and low back function, plantar fascia thickness, and participants' self-reported global improvement. Statistical analysis will be conducted using a two-sided test with a significance level of 0.05 and 95% confidence intervals.
This trial has been registered at the Chinese Clinical Trial Registry. Registration number: ChiCTR2300067552. Registration date: 1 January 2023.
足底筋膜炎是足跟疼痛的常见原因,常与较高的腰痛发生率相关。腰痛致残率的增加可能与足踝功能下降有关。虽然针刺和触发点干针疗法均被报道为治疗足底筋膜炎的潜在有效方法,但目前证据质量较低。触发点针刺可能是治疗足底筋膜炎的一种有前景的方法,尽管缺乏支持其有效性的证据。本试验旨在比较触发点针刺与中医穴位针刺治疗足底筋膜炎合并腰痛患者的疗效。
本试验将是一项单中心、平行两组、随机对照试验,62名参与者按1:1比例分配至触发点组或中医穴位组。患有足底筋膜炎和腰痛的患者将纳入本试验。符合条件的参与者将接受每次30分钟、共8次的针刺治疗,并进行12周的随访。主要结局指标将是治疗后早晨第一步最严重疼痛强度相对于基线的变化。次要结局包括足痛和腰痛、足和腰功能、足底筋膜厚度相对于基线的变化,以及参与者自我报告的整体改善情况。将使用双侧检验进行统计分析,显著性水平为0.05,置信区间为95%。
本试验已在中国临床试验注册中心注册。注册号:ChiCTR2300067552。注册日期:2023年1月1日。